छोड़कर सामग्री पर जाएँ

Latest News

There can be #39;no ifs or buts#39; in dealing with terrorism, says PM Modi in US Congress address

There can be #39;no ifs or buts#39; in dealing with terrorism, says PM Modi in US Congress address

In his address to the joint meeting of the US Congress on Thursday, Prime Minister Modi said that more than two decades after 9/11 and over a decade after the 26/11 attacks in Mumbai, radicalism and terrorism still remain a… और पढ़ें »There can be #39;no ifs or buts#39; in dealing with terrorism, says PM Modi in US Congress address

Announcements in tech space during PM Modi#39;s US visit “big milestone” in India#39;s semiconductor growth story: MoS IT Rajeev Chandrasekhar

Announcements in tech space during PM Modi#39;s US visit “big milestone” in India#39;s semiconductor growth story: MoS IT Rajeev Chandrasekhar

The announcements will create an estimated minimum 80,000 direct jobs, in addition to indirect jobs in supply chain, Chandrasekhar, who is Minister of State for Electronics and IT, said. Read More ​ The announcements will create an estimated minimum 80,000 direct… और पढ़ें »Announcements in tech space during PM Modi#39;s US visit “big milestone” in India#39;s semiconductor growth story: MoS IT Rajeev Chandrasekhar

Aurobindo Pharma gains 2% on subsidiary#39;s licence deal for leukemia drug

Aurobindo Pharma gains 2% on subsidiary#39;s licence deal for leukemia drug

Eugia Pharma has signed a voluntary sub-licensing agreement with Medicines Patent Pool to make and sell Nilotinib capsules, originally developed by Novartis, for chronic myeloid leukemia in 44 low and middle-income countries Read More ​ Eugia Pharma has signed a voluntary… और पढ़ें »Aurobindo Pharma gains 2% on subsidiary#39;s licence deal for leukemia drug

hi_INहिन्दी